In article <
4a9fde92-8b79-4a00...@googlegroups.com>,
Ahasuerus <
ahas...@email.com> wrote:
> On Sunday, October 15, 2017 at 2:46:48 PM UTC-4, Robert Woodward wrote:
> > In article <
slrnou6rpi...@panix2.panix.com>,
> > Carl Fink <
ca...@panix.com> wrote:
> >
> > > On 2017-10-15, James Nicoll <
jdni...@panix.com> wrote:
> > > > Fuzzy Sapiens (Little Fuzzy, book 2) by H. Beam Piper
> > > >
> > > >
http://jamesdavisnicoll.com/review/the-messes-that-you-made
> > >
> > > I read this when it first appeared and haven't thought about it
> > > since then. Thanks for reminding me.
> > >
> > > Also, I had no idea Campbell was so utterly wrongheaded about
> > > drug testing. I knew about his bizarre inertialess drive
> > > nonsense, of course.
> > >
> >
> > I might have to dig out the editorial in question, but, IIRC, Campbell
> > pointed out that what Kelsey was worried about was NOT the potential for
> > birth defects and the additional testing she wanted might not have
> > discovered that. For that matter, I have a vague recollection (from the
> > 80s?) that it doesn't cause birth defects in some species of mammals
> > commonly used for preliminary screening of drugs.
>
> Campbell's _Collected Editorials from Analog_ are available online at
>
https://archive.org/stream/collectededitori01camp/collectededitori01camp_djvu.
> txt
At least the ISFDB identified WHICH issue of ASF this editorial was in
... digging out my copy ... it appears that I didn't remember it
completely correctly. I hadn't remembered the vigor which he had
chastised Kelsey for denying approval for what he considered to be no
rational reason at all (she did this before the problem with peripheral
neuritis was reported). There was no hint in the editorial that Kelsey
wanted the drug tested using a protocol she (and perhaps others at the
FDA) had devised (I consider that rational, perhaps petty-fogging, but
rational - the wikipedia article on Kelsey sort of hints that was the
case).
I did notice his assertion that it wasn't not possible to discover some
side affects for any drug until that drug has been in wide circulation
for years. I recall several recent FDA actions that appear to support
his opinion.
--
"We have advanced to new and surprising levels of bafflement."
Imperial Auditor Miles Vorkosigan describes progress in _Komarr_.
—-----------------------------------------------------
Robert Woodward
robe...@drizzle.com